⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Pedro McdougalM.D. F.A.C.P.

Internal Medicine · Weslaco, TX 78596

NPI: 1144275355

Share:

24

🟡 Moderate

Risk Flags

High long-acting opioid rate vs peersElevated antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

12,365

Total Claims

$1.7M

Drug Cost

2,373

Beneficiaries

$714

Cost/Patient

Risk Score Breakdown 24/100

Low (0)Moderate (15)Elevated (30)High (50+)
Long-acting opioid rate+8
Opioid + benzodiazepine combo+8
Elderly antipsychotic prescribing+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+14%

Opioid rate vs peers

2.6% vs 2.2% avg

-49%

Cost per patient vs peers

$714 vs $1,411 avg

+14%

Brand preference vs peers

12.1% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

2.6%

Opioid Rate

316

Opioid Claims

$6,460

Opioid Cost

29.4%

Long-Acting Rate

Brand vs Generic

88% generic

Brand: 1,470 claims · $1.4M

Generic: 10,670 claims · $261K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Semaglutide87$125K
Dulaglutide80$121K
Empagliflozin76$120K
Sitagliptin Phosphate58$92K
Linagliptin61$81K
Sitagliptin Phos/Metformin Hcl45$60K
Empagliflozin/Metformin Hcl38$57K
Dapagliflozin Propanediol32$54K
Rifaximin15$49K
Insulin Degludec56$48K
Apixaban39$46K
Rivaroxaban27$45K
Linaclotide30$34K
Tirzepatide26$33K
Mirabegron23$24K

Prescribing Profile

155

Unique Drugs

$356K

IRA Negotiated Drugs

$278K

GLP-1 Drugs

24.0

Anomaly Score

Patient Profile

73

Avg Age

61%

Female

2.10

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data